Liver cancers can be efficiently induced in the above-described Tet-MYC mice or in those that constitutively express a human MYC transgene under the control of a synthetic “CAG promoter” that initiates transcription in mid-gestation (ABC-MYC mice) [20,147,149]. Here, MYC is linked to liver cancer.